We have previously demonstrated systemic resistance to methotrexate (MTX) in transgenic mice carrying a foreign, mutant dihydrofolate reductase (DHFR, E.C. 1 S.1.3) gene. The new gene was introduced as a cDNA cloned into an expression vector driven by the simian virus 40 (SV40) early promoter. Previ
Regulation of dihydrofolate reductase gene transcription in methotrexate-resistant mouse fibroblasts
✍ Scribed by Jin-Shyun Ruth Wu; Lee F. Johnson
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 756 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have used a methotrexate‐resistant mouse 3T6 cell line (M50L3) that overproduces dihydrofolate reductase (DHFR) and its mRNA by a factor of about 300 to study the regulation of DHFR hnRNA synthesis. We have previously shown that when resting (G~0~) M50L3 cells are serum stimuled to reenter the cell cycle, the amount and rate of synthesis of DHER and the content of DHER mRNA all begin to increase as the cells enter the S phase of the cell cycle. The increase in DHFR mRNA content is due to an increase in the rate of mRNA production. In the present study, we have used the technique of DNA‐excess filter hybridization to determine the rate of synthesis of DHFR hnRNA relative to total hnRNA at various times following serum stimulation. We found that the relative rate of DHFR hnRNA synthesis began to increase at about the same time (6 hours), and increased to about the same extent (three to fourfold by 15 hours following stimulation) as we observed previously for DHFR mRNA production. This suggests that the increase in DHFR mRNA production (and consequently DHFR gene expression) is controlled primarily, if not exclusively, at the level of transcription. We also studied the effect of addition of high concentrations of dibutyryl cAMP and theophyllne on DHFR gene transciption. We found that addition of these drugs at the time of stimulation completely blocked the increase in DHFR hnRNA synthesis as well as entry into S phase. Addition of the drugs at either 13 or 20 hours following stimulation led to a rapid decrease in DHFR hnRNA synthesis. The drugs were found to have little effect on the ability of the cells to complete S phase when they were added at 13 hours following stimulation. Our results suggest that high intracellular concentrations of cAMP may effect DHFR gene expression not only by preventing the progession of cells through the G~1~ phase of the cell cycle but also by affecting the rate of DHFR gene transcription in a more direct manner.
📜 SIMILAR VOLUMES
We have studied the rate of transcription of t h e gene for dihydrofolate reductase (DHFR) in mouse 3T6 fibroblasts during serum-induced transitions between the resting (Go) and growing states. As a model system, we have used a methotrexate-resistant 3T6 cell line that overproduces DHFR and its mRNA
## Abstract The rate of accumulation of dihydrofolate reductase (DHFR) was studied in resting, growing and serum stimulated mouse 3T6 fibroblasts by first exposing the cells briefly to 10^−6^ M methotrexate (MTX) to inactivate specifically and irreversibly the pre‐existing enzyme, then determining
## Abstract BEN is a member of the TFII‐I family of helix–loop–helix transcription factors. Both TFII‐I and BEN are involved in gene regulation through interactions with tissue‐specific transcription factors and chromatin remodeling complexes. Identification of the downstream target genes of TFII‐I
The growth of capillary endothelial cells (BCE) is an important regulatory step in the formation of capillary blood vessels. In vivo, the proliferation of these cells is stringently controlled. In vitro they can be stimulated by polypeptide growth factors, such as acidic fibroblast growth factor (aF